FDA Approves First Cellular Therapy for Metastatic Melanoma

Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.

Related Keywords

Allison Betof Warner ,Peter Marks ,Melanoma Foundation ,Samanthar Guild ,Drug Administration ,Iovance Biotherapeutics Inc ,Biologics Evaluation ,Betof Warner ,Melanoma Medical Oncology ,Stanford Medicine ,Melanoma ,Malignant Melanoma ,Skin Cancer ,Alignant Skin Neoplasm ,Clinical Research ,Clinical Trials ,Linical Studies ,Pre Clinical Trial ,Double Blind Study ,Double Blind Studies ,Ingle Blind Study ,Ingle Blind Studies ,Braf Inhibitors ,B Raf Inhibitors ,Biologic Therapy ,Iologics ,Kbraf ,Immunotherapy ,Tumor ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,